Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mibc × Gemcitabine × Genitourinary × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 136 Carcinoma, Transitional Cell 48 Non-Muscle Invasive Bladder Neoplasms 28 Urethral Neoplasms 22 Carcinoma, Renal Cell 20 Neoplasms 15 Kidney Neoplasms 15 Pancreatic Neoplasms 14 Ovarian Neoplasms 14 Neoplasm Metastasis 13 Prostatic Neoplasms 12 Carcinoma, Non-Small-Cell Lung 12 Ureteral Neoplasms 9 Colorectal Neoplasms 9 Breast Neoplasms 9 Urologic Neoplasms 7 Lung Neoplasms 7 Testicular Neoplasms 6 Melanoma 6 Stomach Neoplasms 5 Sarcoma 5 Urothelial Cancer 4 Osteosarcoma 4 Colonic Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Recurrence 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Head and Neck Neoplasms 3 Esophageal Neoplasms 3

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06623162 2024-10-04

SASAN-SPARING

Fundación de investigación HM

Phase 2 Not yet recruiting

Mibc

Data powered by HemOnc (CC BY 4.0) Colophon ⚡